Biotechnology Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Instant Alerts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
Biotechnology
Matinas BioPharma Holdings Inc (MTNB) Q2 2024 Earnings Call Transcript Highlights: Financial Improvements and Strategic Progress Amid Challenges
Matinas BioPharma Holdings Inc (MTNB) reports reduced net loss and increased cash reserves, while facing delays and uncertainties in key projects. Aug 16, 2024
Biotechnology
NRX Pharmaceuticals Inc (NRXP) Q2 2024 Earnings Call Transcript Highlights: Significant Cost Reductions and New Funding Boost
NRX Pharmaceuticals Inc (NRXP) reports a nearly 10% reduction in net loss and secures $16 million in new funding, while advancing its clinical development pipeline. Aug 15, 2024
Biotechnology
Arcutis Biotherapeutics Inc (ARQT) Q2 2024 Earnings Call Transcript Highlights: Record Revenue Growth and Strategic Expansions
Arcutis Biotherapeutics Inc (ARQT) reports a 547% year-over-year revenue increase and significant advancements in product offerings and market reach. Aug 15, 2024